<DOC>
	<DOC>NCT02691078</DOC>
	<brief_summary>Evaluation of the properties of the image capture test using 99m Tc - HYNIC -TOC EDDA (octreotide labeled with 99mTc) for the diagnosis of neuroendocrine tumors compared to the 111In - DTPA-octreotide.</brief_summary>
	<brief_title>Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors</brief_title>
	<detailed_description />
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<mesh_term>EDDA</mesh_term>
	<criteria>Patients with histological diagnosis of neuroendocrine tumors Patients with indication for the staging exam with 11In Patients diagnosed in any tumor stage Patients with &gt; 18 years Male and female patients Patients not receiving somatostatin analogues for at least 1 month before image capturing Pregnant women Patients with previous tumor resection of the primary tumor without metastatic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>